Drugs / Influsplit SSW®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00306943 | Jul → Aug 2005 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influsplit SSW | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00306943 ↗ |
| Known as | FluarixTM | “the Influenza vaccine (FluarixTM/ Influsplit SSW®)” NCT00306943 ↗ |
| Modality | Vaccine | “Influenza vaccine” NCT00306943 ↗ |